Article Listing - Sanofi's bid for Aventis cleared by FTC

HOECHST DEFENDS NOMIFENSINE IN SUIT

16 March 1992

The German drugs major Hoechst AG is defending itself against allegations linked to claimed side effects of the company's antidepressant...

ARES-SERONO Rx DRUG SALES UP 15.5%

16 March 1992

On group sales of $751.1 million for the year ended December 31, 1991 (reported in brief last week), Swiss-based Ares-Serono...

US ORPHAN DRUG CHANGE "WOULD BE VETOED"

16 March 1992

The US Bush Administration is strongly opposed to S 2060, the Senate legislation which proposes to end the market monopoly...

FRENCH DOCTORS ATTACK COST DEAL

16 March 1992

The French general practitioners' union, MG-France, has warned of the effects which the health cost control deal just agreed between...

HANTAREX BIOMED LINK WITH SMA?

16 March 1992

A new alliance with possible developments in the biomedical sector has been set up recently in Italy. Under a preliminary...

LIFEGrOUP CHANGES ACQUISITION PLAN

16 March 1992

After a long period of analysis and negotiation, Italy's LIFEGROUP, founded in 1991, has decided against proceeding with the planned...

BEECHAM WITHDRAWS TALPEN FROM UK

16 March 1992

- Beecham Pharma has withdrawn the broad spectrum penicillin antibiotic Talpen (talampicillin hydrochloride) from the UK market on grounds that...

BBG'S DETECTION KITS

16 March 1992

- British Bio-technology Prod-ucts Ltd has expanded its range of in situ hybridization products to include a Detection Module for...

TREATMENT IND FOR AGOURON'S AG-331

16 March 1992

- Oncologists have confirmed that USA-based Agouron Phar-ma's AG-331 has been effective against tumors in animals. The company plans to...

GENZYME AND GLYCOPROTEINS

16 March 1992

- Genzyme Corp, in collaboration with Robert Van Etten and colleagues at Purdue University, Indiana, has developed technol-ogy which could...

Showing 94611-94620 of 95360 articles

Go to beginningPreviousNextGo to end